NDC 70518-4476-01 - Citalopram
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4476
- Requested NDC
- 70518-4476-01
- Package NDCs from labels
- 70518-4476-0, 70518-4476-1, 70518-4476-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Citalopram - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4476-0 | Citalopram | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 3 | |
| 70518-4476-1 | Citalopram | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | Preferred Pharmaceuticals Inc. | 27ddea53-f03d-4760-99bb-ec8efa44ff62 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | ANDA078216 309314 I1E9D14F36 |
| CITALOPRAM | CITALOPRAM | Aurobindo Pharma Limited | 80af8ae8-c106-4895-bab3-0579b41f1e75 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | I1E9D14F36 |
| Citalopram | CITALOPRAM | Bryant Ranch Prepack | bef27fa1-7876-4ce3-834c-a4855aec66c9 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | ANDA078216 200371 I1E9D14F36 |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 7307df53-d570-4e26-971d-e97522ccce7f | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | 200371 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM | Major Pharmaceuticals | a6949652-b15b-435b-9097-2219f398ac05 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | ANDA078216 283672 200371 I1E9D14F36 |
| Citalopram | CITALOPRAM | Chartwell RX, LLC | b1f0c6e8-85eb-4368-8709-9cace32415cb | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | I1E9D14F36 |
| Citalopram | CITALOPRAM | Torrent Pharmaceuticals Limited | 04766f1d-7a69-49ed-8fd3-1a6305505d47 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | ANDA078216 13668-009 283672 200371 309314 48423caf-4df2-4653-a8ed-b28462757ed3 04766f1d-7a69-49ed-8fd3-1a6305505d47 I1E9D14F36 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | Preferred Pharmaceuticals, Inc. | b52acd68-fed1-4680-9eaf-b72e7dcba6fb | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | ANDA078216 283672 200371 I1E9D14F36 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f2b42bdc-47e0-19c5-e053-2a95a90a1828 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 200371 I1E9D14F36 |
| Citalopram | CITALOPRAM | Chartwell Governmental & Specialty RX, LLC. | 3114274f-d81f-4b1f-8f17-35db9eee2ffe | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | I1E9D14F36 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f2b54f10-221f-5eed-e053-2995a90ab47f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Northwind Health Company, LLC | d9cc1649-913d-832d-e053-2995a90a5f9a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 283672 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Northwind Health Company, LLC | d9ccb3fb-b607-9491-e053-2995a90a39c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 200371 I1E9D14F36 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | a7ef6ad2-5f22-4ac7-b57a-f498bcb53be1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA078216 200371 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f77ef23b-3015-d074-e053-6394a90a11e1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 283672 I1E9D14F36 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | Northwind Health Company, LLC | c133fc77-6c8a-d2b1-e053-2995a90ab5f7 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | ANDA078216 283672 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | QPharma, Inc. | 0a967468-3869-4c8c-849f-9fc3a8dcc489 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 200371 I1E9D14F36 |
| Citalopram | CITALOPRAM | Advanced Rx of Tennessee, LLC | 434094b4-fa3b-385a-e063-6394a90ac638 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | ANDA078216 283672 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | PD-Rx Pharmaceuticals, Inc. | 31a18cdf-b0aa-18f5-e054-00144ff8d46c | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
| Citalopram | CITALOPRAM HYDROBROMIDE | NuCare Pharmaceuticals,Inc. | 544ba802-a536-579a-e054-00144ff88e88 | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | 309314 I1E9D14F36 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.